3:00  –  3.05 PM

Opening of the conference – Prof. Andrzej Grzybowski, MD, PhD

3.05 – 3.20 PM

Introductory lecture – Myopia prevention and control: it is time to measure what we do, Prof. Serge Resnikoff, MD, PhD, The Chair of the International Myopia Institute

Session I

3.20 – 3.30 PM

Possible effect of Induced Spherical Aberrations (Z04) on Myopia Control by OrthoKeratology. Dr. Andriy Kovalov, MD, PhD. Ophthalmologist Consultant of AILAS Medical Center (Kyiv, Ukraine)

3.30 – 3.40 PM

Indications of favorable structural changes during ortho-k treatment. Dr. Trine Møldrup Jakobsen, MD, PhD, Department of Ophthalmology, University Hospital of Southern Denmark; Institution of Regional Research, University of Southern Denmark, Sønderborg, Denmark

3.40 – 3.50 PM

Twenty Years of Orthokeratology in Real Life: Efficacy, Safety and Predictors of Myopia Progression. Dr. Beata Tapasztó, MD, PhD, Semmelweis University, Department of Ophthalmology, Budapest, Hungary; Semmelweis University, Faculty of Health Sciences, Budapest, Hungary

3.50 – 4.00 PM

The evaluation of methods and the success of optical interventions in a real-world population. Dr. Stephanie Kearney, PhD, Glasgow Caledonian University, Glasgow, UK

4.00 – 4.10 PM

Myopia and strabismus. Dr Pilar Merino Sanz, MD, PhD, Department of Ophthalmology, Hospital Universitario Gregorio Marañón, Madrid, Spain; President of the Spanish Society of Strabismus and Pediatric Ophthalmology (SEEOP)

4.10 – 4.20 PM

Myopia Management in Europe. European Myopia Network White Paper. Prof. Andrzej Grzybowski, MD, PhD, Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznań, Poland; University of Warmia and Mazury, Olsztyn, Poland

4.20 – 4.30 PM

Implementing Interdisciplinary Clinical Workflows in Modern Myopia Management

4.30 – 4.40 PM

TBC

4.40 – 4.50 PM

TBC

4.50 – 5.00 PM

TBC

5.00 – 5.15 PM

Discussion

Session II (5:15 – 7:10 PM)

Reporting myopia-control efficacy as physiological axial growth and NNT (number needed to treat). Prof. Hakan Kaymak, MD, PhD, I.I.O. GbR, Düsseldorf, Germany; Gottfried O.H. Naumann Institute for Epidemiology and Prevention of Myopia, Saarland University, Homburg, Germany

Light-Based Interventions to Slow Myopia Progression: Current Evidence. Prof. Carla Lanca, PhD, New York University Abu Dhabi, UAE

Update on the Prevalence of Myopia in Europe. Prof. Miguel Á. Sánchez-Tena, PhD (Department of Optometry and Vision, Complutense University of Madrid, Spain) and Prof. Cristina Alvarez-Peregrina PhD (Complutense University of Madrid, Spain)

Association of time spent on near work and outdoors with the prevalence and progression of myopia. Prof. Olavi Pärssinen MD, PhD, CREAM Consortium, MRC Consortium, Finland

Who Should Be Treated for Myopia? Dr. Jelena Škunca Herman, MD, PhD, Department of Pediatric Ophthalmology and Strabismus, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

Population study – Myopia screening among first-grade students in Tromsø, Norway. Dr. Aleksandar Stojanovic, MD, PhD, FWCRS, University Hospital of North Norway, Tromsø, Norway; SynsLaser Surgery Clinics, Tromsø and Oslo, Norway

One-year efficacy and tolerability of 0.05% atropine for myopia control in Estonia, Teele Palumaa, MD, DPhil, Department of Ophthalmology, Emory University, USA, Institute of Genomics, University of Tartu, Estonia

TBC

TBC

TBC

Discussion

Closing of the conference – Prof. Andrzej Grzybowski, MD, PhD